Navigation Links
Premier Wen Visits Asymchem's Tianjin Facility
Date:11/10/2011

TIANJIN, China, Nov. 10, 2011 /PRNewswire/ -- Asymchem Life Science (Tianjin) Co. Ltd., a leading research-based contract manufacturer of intermediates, API's and Drug Products for the pharmaceutical industry with sites in the U.S. and China, was pleased to receive a visit from Premier Wen Jiabao at its GMP R&D and manufacturing facility on the afternoon of October 24th, 2011. Premier Wen, a member of the Standing Committee of the Political Bureau of the CPC Central Committee and Premier of the State Council, visited Asymchem during his investigative trip to observe the development of Tianjin Binhai New Area where Asymchem is based. Premier Wen was accompanied by Mr. Zhang Gaoli, the Tianjin Municipal Committee Secretary.

During his visit, Premier Wen praised the CEO of Asymchem, Dr. Hao Hong, for Asymchem's growth. Asymchem has risen from a company with $250,000 USD in registered capital to one with $65 million USD in manufacturing output. Dr. Hong states, "Premier Wen spoke highly of Asymchem's innovation and its presence as a leading Chinese pharmaceutical company, which has the power to attract international talents."

Premier Wen also visited the Analysis and Testing Center and the process R&D center at Asymchem, commenting positively on Asymchem's dual focus on internationally advanced facilities and the involvement of high-tech talents. Dr. Hong adds, "Through the pursuance of high-tech innovation, Asymchem will continue to contribute to the development of the biopharmaceutical and strategically important new industries in the Tianjin Binhai New Area and throughout the whole of China."

With a diverse range of capabilities ranging from the synthesis of sophisticated organic chemicals in the lab to commercial scale production of API's, Asymchem offers a comprehensive list of services for pharmaceutical customers. For more information on Asymchem, please visit our website at www.asymchem.com.


'/>"/>
SOURCE Asymchem Life Science (Tianjin) Co. Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin Becomes Premier Founding Sponsor of RMECs New Osteobiologics Registry
2. BioNeutral to Premier its EPA-Approved Ygiene® 206 Hospital-Grade Disinfectant at the Annual 2011 APIC Conference, While Community Health of South Florida Begins Product Review
3. Mathematics and Biochemistry Research Earn Top Prize at Nations Premier High School Science Competition
4. Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept. 29
5. Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)
6. Vistaar and the Professional Pricing Society Partner to Present Premier Symposium for Pricing Practitioners
7. Mexico Premiere for Money-Saving Pharma Leak Testing Equipment
8. Chinas Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation
9. Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance
10. Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nations Premier High School Science Competition
11. Premier Research Achieves Double-Digit Growth in Functional Sourcing for the Third Straight Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of 8.5 ... end machines that use the more unconventional z-dimension of 20mm. Z-dimension or ... the cuvette holder. , FireflySci has developed several Agilent flow cell product lines ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
Breaking Biology Technology:
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
(Date:3/21/2016)... Unique technology combines v ... security   Xura, Inc. ... digital communications services, today announced it is working alongside ... customers, particularly those in the Financial Services Sector, the ... within a mobile app, alongside, and in combination with, ...
Breaking Biology News(10 mins):